Cargando…

Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis

Prophylactic administration of CpG oligodeoxynucleotides (CpG ODNs) is known to confer protection against lethal sepsis caused by Burkholderia pseudomallei in the mouse model. The mechanisms whereby CpG regulates the innate immune response to provide protection against B. pseudomallei, however, are...

Descripción completa

Detalles Bibliográficos
Autores principales: Judy, Barbara M., Taylor, Katherine, Deeraksa, Arpaporn, Johnston, R. Katie, Endsley, Janice J., Vijayakumar, Sudhamathi, Aronson, Judith F., Estes, D. Mark, Torres, Alfredo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309019/
https://www.ncbi.nlm.nih.gov/pubmed/22448290
http://dx.doi.org/10.1371/journal.pone.0034176
_version_ 1782227476986986496
author Judy, Barbara M.
Taylor, Katherine
Deeraksa, Arpaporn
Johnston, R. Katie
Endsley, Janice J.
Vijayakumar, Sudhamathi
Aronson, Judith F.
Estes, D. Mark
Torres, Alfredo G.
author_facet Judy, Barbara M.
Taylor, Katherine
Deeraksa, Arpaporn
Johnston, R. Katie
Endsley, Janice J.
Vijayakumar, Sudhamathi
Aronson, Judith F.
Estes, D. Mark
Torres, Alfredo G.
author_sort Judy, Barbara M.
collection PubMed
description Prophylactic administration of CpG oligodeoxynucleotides (CpG ODNs) is known to confer protection against lethal sepsis caused by Burkholderia pseudomallei in the mouse model. The mechanisms whereby CpG regulates the innate immune response to provide protection against B. pseudomallei, however, are poorly characterized. In the present study, we demonstrate that intranasal treatment of mice with Class C CpG, results in recruitment of inflammatory monocytes and neutrophils to the lung at 48 h post-treatment. Mice infected with B. pseudomallei 48 h post-CpG treatment had reduced organ bacterial load and significantly altered cytokine and chemokine profiles concomitant with protection as compared to control animals. CpG administration reduced the robust production of chemokines and pro-inflammatory cytokines in blood, lung and spleen, observed following infection of non-treated animals. Death of control animals coincided with the time of peak cytokine production (day 1–3), while a moderate; sustained cytokine production in CpG-treated animals was associated with survival. In general, CpG treatment resulted in diminished expression of cytokines and chemokines post-infection, though IL-12p40 was released in larger quantities in CpG treated animals. In contrast to CpG-treated animals, the lungs of infected control animals were infiltrated with leukocytes, especially neutrophils, and large numbers of necrotic lesions were observed in lung sections. Therapeutic treatment of B. pseudomallei-infected animals with CpG at 24 h post-infection did not impact survival compared to control animals. In summary, protection of CpG-treated animals was associated with recruitment of inflammatory monocytes and neutrophils into the lungs prior to infection. These responses correspond with early control of bacterial growth, a dampened inflammatory cytokine/chemokine response, reduced lung pathology, and greatly increased survival. In contrast, a delay in recruitment of inflammatory cell populations, despite a robust production of pro-inflammatory cytokines, was associated with poorly controlled bacterial growth, severe lung pathology, and death of control animals.
format Online
Article
Text
id pubmed-3309019
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33090192012-03-23 Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis Judy, Barbara M. Taylor, Katherine Deeraksa, Arpaporn Johnston, R. Katie Endsley, Janice J. Vijayakumar, Sudhamathi Aronson, Judith F. Estes, D. Mark Torres, Alfredo G. PLoS One Research Article Prophylactic administration of CpG oligodeoxynucleotides (CpG ODNs) is known to confer protection against lethal sepsis caused by Burkholderia pseudomallei in the mouse model. The mechanisms whereby CpG regulates the innate immune response to provide protection against B. pseudomallei, however, are poorly characterized. In the present study, we demonstrate that intranasal treatment of mice with Class C CpG, results in recruitment of inflammatory monocytes and neutrophils to the lung at 48 h post-treatment. Mice infected with B. pseudomallei 48 h post-CpG treatment had reduced organ bacterial load and significantly altered cytokine and chemokine profiles concomitant with protection as compared to control animals. CpG administration reduced the robust production of chemokines and pro-inflammatory cytokines in blood, lung and spleen, observed following infection of non-treated animals. Death of control animals coincided with the time of peak cytokine production (day 1–3), while a moderate; sustained cytokine production in CpG-treated animals was associated with survival. In general, CpG treatment resulted in diminished expression of cytokines and chemokines post-infection, though IL-12p40 was released in larger quantities in CpG treated animals. In contrast to CpG-treated animals, the lungs of infected control animals were infiltrated with leukocytes, especially neutrophils, and large numbers of necrotic lesions were observed in lung sections. Therapeutic treatment of B. pseudomallei-infected animals with CpG at 24 h post-infection did not impact survival compared to control animals. In summary, protection of CpG-treated animals was associated with recruitment of inflammatory monocytes and neutrophils into the lungs prior to infection. These responses correspond with early control of bacterial growth, a dampened inflammatory cytokine/chemokine response, reduced lung pathology, and greatly increased survival. In contrast, a delay in recruitment of inflammatory cell populations, despite a robust production of pro-inflammatory cytokines, was associated with poorly controlled bacterial growth, severe lung pathology, and death of control animals. Public Library of Science 2012-03-20 /pmc/articles/PMC3309019/ /pubmed/22448290 http://dx.doi.org/10.1371/journal.pone.0034176 Text en Judy et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Judy, Barbara M.
Taylor, Katherine
Deeraksa, Arpaporn
Johnston, R. Katie
Endsley, Janice J.
Vijayakumar, Sudhamathi
Aronson, Judith F.
Estes, D. Mark
Torres, Alfredo G.
Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis
title Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis
title_full Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis
title_fullStr Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis
title_full_unstemmed Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis
title_short Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis
title_sort prophylactic application of cpg oligonucleotides augments the early host response and confers protection in acute melioidosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309019/
https://www.ncbi.nlm.nih.gov/pubmed/22448290
http://dx.doi.org/10.1371/journal.pone.0034176
work_keys_str_mv AT judybarbaram prophylacticapplicationofcpgoligonucleotidesaugmentstheearlyhostresponseandconfersprotectioninacutemelioidosis
AT taylorkatherine prophylacticapplicationofcpgoligonucleotidesaugmentstheearlyhostresponseandconfersprotectioninacutemelioidosis
AT deeraksaarpaporn prophylacticapplicationofcpgoligonucleotidesaugmentstheearlyhostresponseandconfersprotectioninacutemelioidosis
AT johnstonrkatie prophylacticapplicationofcpgoligonucleotidesaugmentstheearlyhostresponseandconfersprotectioninacutemelioidosis
AT endsleyjanicej prophylacticapplicationofcpgoligonucleotidesaugmentstheearlyhostresponseandconfersprotectioninacutemelioidosis
AT vijayakumarsudhamathi prophylacticapplicationofcpgoligonucleotidesaugmentstheearlyhostresponseandconfersprotectioninacutemelioidosis
AT aronsonjudithf prophylacticapplicationofcpgoligonucleotidesaugmentstheearlyhostresponseandconfersprotectioninacutemelioidosis
AT estesdmark prophylacticapplicationofcpgoligonucleotidesaugmentstheearlyhostresponseandconfersprotectioninacutemelioidosis
AT torresalfredog prophylacticapplicationofcpgoligonucleotidesaugmentstheearlyhostresponseandconfersprotectioninacutemelioidosis